Aligos Therapeutics has secured a…
Aligos Therapeutics has secured a $25 million upfront fee from [...]
Aligos Therapeutics has secured a $25 million upfront fee from [...]
The Spanish government has announced a goal to raise a [...]
The steady stream of IPOs evaporated almost as quickly as [...]
Terremoto Biosciences has spelt out how the California biotech will [...]
After initiating a wind-down more than 18 months ago and [...]
Astellas is preparing to close its Seattle site for its [...]
Takeda has pulled back from a research collaboration with a [...]
An FDA review of records found that results have not [...]
Kailera is taking another step into the competitive obesity market [...]
Spyre Therapeutics’ monoclonal antibody hit the key goal in a [...]